The complete treatment of cases PB=6 doses in 6 months); Cases MB-12 or 24 cellophanes (1 cartela=1 dose for month. The complete treatment of this case = 12 or 24 doses in 24 months); pregnant women also must be treated, after to complete the treatment the patient will be cured (CONASEMS, 1999). Goldman and Ausiello (2005), recommend that the drug more comumente used in the therapy of the leprosy is 4,4-diamino-difenilsulfona; Dapsona, DDS. Due to emergency spread of cepas of M. Leprae resistant the Dapsona, currently all the patients receive therapies multidrugs.

the components and projects vary depending on the sensible presence of cepas to the Dapsona and of the region in which the patient inhabits. The OMS has as project the intermittent therapy with rifampicina has for base its cost and the clinical and laboratoriais studies, some leprologistas use the rifampicina in the 600 daily doses of 450 mg for two the three years. The clofazimina, one derived from fenazina, presents some ackward collateral effect on the basis of its lipofilicidade, causing fidget in people of clear skin, if it deposits in the thin intestine, where in high concentrations cause segmentary espessamento associate pain in clicas and diarria. The Leprosy infectious illness, exists capacity of cure with appropriate medicines. A time identifying a case in I domiciliate the ACS must direct this patient to the next attendance of health so that careful clinical examination of all is carried through the contacts following for bipsia of the injuries suspicion. The threat of I infect is very bigger in children with less than 16 years. In this adolescent category, the prophylactic use of Dapsona must be considered (GOLDMAN; AUSIELLO, 2005). FINAL CONSIDERAES The Hansenase is an infectious illness of aspect caused by the Mycobacterium leprae, that it has discontinous chronic course for reacionais surtos, affecting the peripheral skin and nerves that not yet were abolished in the world.